Invention Grant
- Patent Title: Imidazoquinoxaline compounds as immunomodulators
- Patent Title (中): 咪唑喹喔啉化合物作为免疫调节剂
-
Application No.: US12294233Application Date: 2007-03-23
-
Publication No.: US08173657B2Publication Date: 2012-05-08
- Inventor: James Sutton , Feng Xu , Nicholas Valiante , Jiong Lan
- Applicant: James Sutton , Feng Xu , Nicholas Valiante , Jiong Lan
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Helen Lee; Robert Gorman; Otis Littlefield
- International Application: PCT/US2007/064858 WO 20070323
- International Announcement: WO2007/109813 WO 20070927
- Main IPC: A61K31/50
- IPC: A61K31/50 ; A61K39/02 ; A61K39/12 ; A61K39/00 ; C07D471/00 ; C07D487/00
Abstract:
The invention provides novel compositions comprising imidazoquinoxaline compounds of formula (I) and analogs thereof. Also provided are methods of administering the compositions in an effective amount to enhance the immune response of a subject. Further provided are novel compositions and methods of administering the compositions in combination with (an) other agent(s).
Public/Granted literature
- US20090311288A1 IMIDAZOQUINOXALINE COMPOUNDS AS IMMUNOMODULATORS Public/Granted day:2009-12-17
Information query
